Product Images Diovan Hct
View Photos of Packaging, Labels & Appearance
- NDC 68258-6053-XX - NDC 68258 6053 XX NOVARTIS
- Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - diovan hct 01
- Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - diovan hct 02
- Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - diovan hct 03
- Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - diovan hct 04
- Valsartan structural formula - diovan hct 05
- Hydrochlorothiazide structural formula - diovan hct 06
Product Label Images
The following 7 images provide visual information about the product associated with Diovan Hct NDC 68258-6053 by Dispensing Solutions, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
NDC 68258-6053-XX - NDC 68258 6053 XX NOVARTIS

This is a description of a medication distributed by Novartis Pharmaceuticals Corporation. The medication is an ovaloid tablet with slightly convex faces, debossed with NVR/HXH. The medication is called DIOVAN HCT 160 mg/25 mg and contains Valsartan USP and Hydrochlorothiazide USP. It is dispensed in a tight and light-resistant container and should be taken orally once daily. The medication can cause drowsiness, dizziness, or headache and should not be discontinued without a doctor's advice. It is also warned that the medicine should be kept out of children's reach and stored at 77°F.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.